Study finds older Americans are largely unaware of new Alzheimer's drug
There's a new drug to treat Alzheimer's disease, but those who might benefit from it know almost nothing about it, a new study shows.
Feb 17, 2022
1
123
There's a new drug to treat Alzheimer's disease, but those who might benefit from it know almost nothing about it, a new study shows.
Feb 17, 2022
1
123
An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease. The national Alzheimer's Association predicts that number to grow to 13.8 million by 2060, barring the development of medical breakthroughs ...
Nov 2, 2022
0
58
Neurologists must make sure Alzheimer's patients and their families understand that the controversial drug aducanumab does not restore mental function, the American Academy of Neurology (AAN) said in new position statement ...
Nov 18, 2021
0
11
To help neurologists, patients and their families understand the current evidence on the use of aducanumab to treat Alzheimer's disease, the American Academy of Neurology (AAN) has issued an evidence-in-focus article, published ...
Feb 23, 2022
0
0
In June 2021, the Food & Drug Administration (FDA) granted accelerated approval for aducanumab to treat patients with mild cognitive impairment or mild dementia due to Alzheimer's disease. The two phase-3 clinical trials ...
Sep 9, 2021
0
3
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy ...
Jul 6, 2021
0
5
Using current techniques, Alzheimer's disease, the most frequent cause of dementia, can only be detected once characteristic plaques have formed in the brain. At this point, therapy is no longer possible. However, the first ...
May 6, 2019
0
4
Earlier this week, the federal Food and Drug Administration (FDA) approved the use of the drug aducanumab to treat Alzheimer's disease—making it the first new drug in nearly 20-years to treat the disease. Aducanumab is ...
Jun 10, 2021
0
0
The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer's disease. But approval of the drug has provoked mixed reactions from the scientific ...
Jun 16, 2021
0
5